First, there is certainly the molecule itself. According to the available preclinical information, the BPC-157 peptide sequence seems to possess a remarkably superior protection profile. In animal studies, even at doses appreciably better than what is usually used in investigate options, researchers haven't documented catastrophic adverse gathering